Table 1.
Baseline characteristics in subjects with HAS on baseline CT by treatment group
| Subject characteristics | rt-PA (n=37) |
Placebo (n=42) |
p-value |
|---|---|---|---|
| Age | 69.6 ± 10.9 | 63.7 ± 11.7 | 0.02 |
| Sex (female) | 22 (59.5%) | 31 (73.8%) | 0.18 |
| Time to treatment (hours) | 1.95 ± 0.59 | 1.94 ± 0.58 | 0.94 |
| Hypertension | 22 (59.5%) | 25 (61.0%) | 0.89 |
| Diabetes | 4 (10.8%) | 7 (16.7%) | 0.45 |
| Presenting NIHSS | 20 (17, 24) | 18 (15, 23) | 0.20 |
| Admission MAP | 105.8 ± 13.6 | 108.4 ± 13.5 | 0.40 |
| Glucose (mg/dL) | 137.8 ± 48.4 | 162.8 ± 87.7 | 0.12 |
Data presented as mean ± standard deviation, n (%), or median (25th, 75th percentiles)